Pancragen

Moderate Research

Tetrapeptide bioregulator

Pancragen is a peptide bioregulator that has been studied in pancreatic research for its effects on pancreatic tissue gene expression. Published research has investigated its role in pancreatic tissue regulation. RaysunPeptide supplies Pancragen for qualified research and laboratory applications.

Mechanism of Action

Pancragen works through epigenetic regulation by interacting with chromatin complexes and DNA structures to modulate pancreatic gene expression. Research shows it upregulates critical transcription factors for pancreatic cell maturation including Pdx1, Pax6, Ptf1a, Foxa2, Nkx2.2, and Pax4.

Key Benefits

1Corrects impaired glucose tolerance
2Normalizes insulin levels
3Normalizes C-peptide levels
4Improves endocrine pancreatic function
5Supports pancreatic cell differentiation
6Regulates melatonin expression
7Reduces metabolic syndrome incidence
8Upregulates key pancreatic transcription factors

Molecular Data

Molecular Weight
576 Da
Half-Life
Not established
Chain Length
4 amino acids
Amino Acid Sequence
KEDW

Dosing Protocols

GoalDoseFrequencyRoute
Standard protocol10-20 mgDaily for 10-20 daysOral capsules
Maintenance10 mg2-3 cycles yearlyOral capsules

Research Indications

Metabolic Support

Impaired Glucose Toleranceeffective

Corrects age-related glucose tolerance disturbances in primate studies.

Metabolic Syndromemoderate

Reduces incidence and magnitude of metabolic syndrome.

Blood Sugar Regulationmoderate

Helps control blood sugar through pancreatic function support.

Pancreatic Health

Pancreatic Cell Differentiationeffective

Impacts differentiation of pancreatic cells during aging.

Endocrine Functioneffective

Improves endocrine function of the pancreas.

Age-Related Pancreatic Declinemoderate

Addresses age-related imbalance of pancreatic function.

Anti-Aging

Gene Expression Regulationmoderate

Directly interacts with DNA to regulate pancreatic gene expression.

Peptide Interactions

Epitalon++ synergistic

Often combined in comprehensive anti-aging Khavinson protocols.

Livagen+ compatible

Different organ targets; can be used in comprehensive bioregulator protocols.

Vilon+ compatible

Part of Khavinson bioregulator family; targets different tissue.

GLP-1 agonists~ monitor

Both affect glucose metabolism; interaction unknown.

What to Expect

1
During cycle
Gene expression modulation begins
2
Post-cycle
Effects persist due to epigenetic changes
3
Weeks-Months
Glucose tolerance and pancreatic function improvements
4
Long-term
Cumulative benefits with periodic cycles

Side Effects & Safety

Common (Generally Mild)

  • •Generally well-tolerated
  • •Minimal side effects reported

Stop Signs (Seek Medical Attention)

  • ⚠Allergic reactions
  • ⚠Unusual blood sugar changes
  • ⚠Signs of hypoglycemia

Contraindications

  • ✕Active pancreatic emergencies (seek medical care)
  • ✕Known hypersensitivity
  • ✕Pregnancy or breastfeeding
  • ✕Type 1 diabetes (consult physician)

Quality Checklist

Good Signs ✓

  • White powder or capsules
  • Clear solution if reconstituted
  • Proper packaging and labeling

Warning Signs !

  • Unknown source or purity

Bad Signs ✕

  • Discoloration
  • Unusual odor
  • Damaged packaging

References

Correction of Impaired Glucose Tolerance Using Tetrapeptide (Pancragen) in Old Female Rhesus Monkeys
• PubMed • 2017

Pancragen normalized insulin and C-peptide levels, suggesting recovery of disturbed glucose tolerance in old animals.

Tetrapeptide KEDW Interacts with DNA and Regulates Gene Expression
• Bulletin of Experimental Biology and Medicine • 2015

KEDW directly interacts with DNA and regulates pancreatic gene expression.

Impacts of Pancragen on Differentiation of Pancreatic Cells During Aging
• Bulletin of Experimental Biology and Medicine • 2013

Pancragen affects pancreatic cell differentiation during aging process.

Prospects of Using Pancragen for Metabolic Disorders in Elderly
• Bulletin of Experimental Biology and Medicine • 2011

Pancragen shows promise for correction of metabolic disorders in elderly people.

FAQs

Does Pancragen actually cure glucose intolerance, or just mask it?

Pancragen works through epigenetic regulation—it directly interacts with DNA to upregulate pancreatic transcription factors. In primate studies, it normalized insulin and C-peptide levels, suggesting actual restoration of pancreatic function rather than masking. However, this only works for age-related glucose tolerance decline, not for Type 1 diabetes or severe pancreatic damage.

Can I take Pancragen if I have Type 1 diabetes?

The contraindications specifically list Type 1 diabetes as requiring physician consultation. Type 1 involves autoimmune pancreatic destruction, which is different from the age-related metabolic decline Pancragen targets.

How long before Pancragen improves my blood sugar levels?

Pancragen works through gene expression changes, so results are cumulative. During the 10-20 day cycle, transcription factors are upregulated, but visible glucose improvements typically emerge over weeks to months.

Should I monitor my blood sugar more closely while taking Pancragen?

Yes. The file specifically recommends blood glucose monitoring and HbA1c testing with long-term use.

Pancragen

Dosing Summary

Dose
10-20mg daily
Frequency
Daily for 10-20 days per cycle
Cycle
10-20 days
Storage
Capsules at room temperature; reconstituted injectable at 2-8°C refrigerated

Specifications

Purity≥98% (HPLC verified)
FormLyophilized powder
Packaging20mg
StorageStore at -20°C, protect from light
Catalog No.PA20

Research Data

4
Studies
2017
Latest
4
Recent

Available Sizes

20mg$30